Clinical trials
Infections trials in Italy with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 4 |
| Suspended | 1 |
| Terminated | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Bari | 2 |
| Azienda Ospedaliera Universitaria Policlinico "G. Martino" | 1 |
| Campus Bio-Medico University | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Federico II University | 1 |
| IRCCS Policlinico S. Donato | 1 |
| IRCCS Sacro Cuore Don Calabria di Negrar | 1 |
| Istituto Clinico Humanitas | 1 |
| Liaquat University of Medical & Health Sciences | 1 |
| Regina Elena Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infections | 15 |
| Acquired Immunodeficiency Syndrome | 1 |
| Blast Crisis | 1 |
| Burkitt Lymphoma | 1 |
| Cicatrix | 1 |
| Congenital Abnormalities | 1 |
| Fever | 1 |
| Graft vs Host Disease | 1 |
| HIV Infections | 1 |
| Heart Defects, Congenital | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.